A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis.

PURPOSE This multicenter, double-blind clinical trial evaluated and compared the efficacy and safety of PRGF-Endoret (BTI Biotechnology Institute, Vitoria-Gasteiz, Spain), an autologous biological therapy for regenerative purposes, versus hyaluronic acid (HA) as a short-term treatment for knee pain from osteoarthritis. METHODS We randomly assigned 176 patients with symptomatic knee osteoarthritis to receive infiltrations with PRGF-Endoret or with HA (3 injections on a weekly basis). The primary outcome measure was a 50% decrease in knee pain from baseline to week 24. As secondary outcomes, we also assessed pain, stiffness, and physical function using the Western Ontario and McMaster Universities Osteoarthritis Index; the rate of response using the criteria of the Outcome Measures for Rheumatology Committee and Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative (OMERACT-OARSI); and safety. RESULTS The mean age of the patients was 59.8 years, and 52% were women. Compared with the rate of response to HA, the rate of response to PRGF-Endoret was 14.1 percentage points higher (95% confidence interval, 0.5 to 27.6; P = .044). Regarding the secondary outcome measures, the rate of response to PRGF-Endoret was higher in all cases, although no significant differences were reached. Adverse events were mild and evenly distributed between the groups. CONCLUSIONS Plasma rich in growth factors showed superior short-term results when compared with HA in a randomized controlled trial, with a comparable safety profile, in alleviating symptoms of mild to moderate osteoarthritis of the knee. LEVEL OF EVIDENCE Level I, randomized controlled multicenter trial.

[1]  M. Dougados,et al.  OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. , 2004, Osteoarthritis and cartilage.

[2]  Sandro Giannini,et al.  Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. , 2011, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[3]  H. Weinans,et al.  Platelet-Rich Plasma Releasate Inhibits Inflammatory Processes in Osteoarthritic Chondrocytes , 2011, The American journal of sports medicine.

[4]  Walter Grassi,et al.  Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale , 2004, European journal of pain.

[5]  M. Goldring,et al.  Cartilage homeostasis in health and rheumatic diseases , 2009, Arthritis research & therapy.

[6]  Stephan R Williams,et al.  Complication during ultrasound-guided regional block: accidental intravascular injection of local anesthetic. , 2008, Anesthesiology.

[7]  F. Legendre,et al.  Interleukin-1 and Transforming Growth Factor-ß 1 as Crucial Factors in Osteoarthritic Cartilage Metabolism , 2008, Connective tissue research.

[8]  H. Sørensen,et al.  Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. , 2005, Archives of internal medicine.

[9]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. , 2007, Osteoarthritis and cartilage.

[10]  Gorka Orive,et al.  Potential of endogenous regenerative technology for in situ regenerative medicine. , 2010, Advanced drug delivery reviews.

[11]  E. Anitua,et al.  Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. , 2008, Clinical and experimental rheumatology.

[12]  J. Wang,et al.  Platelet-Rich Plasma Releasate Promotes Differentiation of Tendon Stem Cells into Active Tenocytes , 2010, The American journal of sports medicine.

[13]  D. Zukor,et al.  Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production. , 2006, The American journal of pathology.

[14]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[15]  S. Giannini,et al.  Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis , 2011, Knee Surgery, Sports Traumatology, Arthroscopy.

[16]  J. Woodell-May,et al.  Autologous protein solution inhibits MMP‐13 production by IL‐1β and TNFα‐stimulated human articular chondrocytes , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  S. Lynch,et al.  A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. , 2006, Osteoarthritis and cartilage.

[18]  Raveendhara R. Bannuru,et al.  Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. , 2010, Osteoarthritis and cartilage.

[19]  M. Marcacci,et al.  Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach , 2012, Knee Surgery, Sports Traumatology, Arthroscopy.

[20]  A. Nurden,et al.  Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. , 2007, Rheumatology.

[21]  D. Harvanova,et al.  Treatment of Knee Joint Osteoarthritis with Autologous Platelet-Rich Plasma in Comparison with Hyaluronic Acid , 2012, American journal of physical medicine & rehabilitation.

[22]  L. Lohmander,et al.  Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. , 2002, Rheumatology.

[23]  R. Cugat,et al.  Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life , 2011, Archives of Orthopaedic and Trauma Surgery.

[24]  Prevalence of disabilities and associated health conditions among adults--United States, 1999. , 2001, MMWR. Morbidity and mortality weekly report.

[25]  D. Zukor,et al.  Transforming Growth Factor- (cid:1) 2 Suppresses Collagen Cleavage in Cultured Human Osteoarthritic Cartilage, Reduces Expression of Genes Associated with Chondrocyte Hypertrophy and Degradation, and Increases Prostaglandin E 2 Production , 2022 .

[26]  G. Orive,et al.  Fibroblastic response to treatment with different preparations rich in growth factors , 2009, Cell proliferation.

[27]  G. Banfi,et al.  Molecular basis of anti‐inflammatory action of platelet‐rich plasma on human chondrocytes: Mechanisms of NF‐κB inhibition via HGF , 2010, Journal of cellular physiology.

[28]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[29]  P. Wolf,et al.  The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.

[30]  M. Rowbotham.  What is a ‘clinically meaningful’ reduction in pain? , 2001, PAIN.

[31]  M. Müllner,et al.  Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis , 2005, Canadian Medical Association Journal.

[32]  G. Herrero-Beaumont,et al.  A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project , 2011, Annals of the rheumatic diseases.